Many people who wish to quit smoking just give up within no time. It's not that you don't want to; maybe there are a few ...
With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in ...
The pharmaceutical company Qnovia announced that the FDA approved its experimental nicotine inhaler for trial in the U.S. The ...
double-blind placebo-controlled study evaluated the efficacy and safety of nicotine 4 mg gum or nicotine 10 mg inhaler in helping smokers (N = 314) to reduce or quit smoking. It included smokers ...
- The study will evaluate the pharmacokinetics, safety and tolerability of the RespiRx â„¢ Nicotine Inhaler compared to Nicotrol ® Inhaler and combustible cigarettes - RICHMOND, Va., Oct. 1 ...
RespiRx â„¢ Nicotine Inhaler (QN-01). The RespiRx is a drug device combination product that is the first truly inhalable nicotine replacement therapy (NRT) to assist smokers attempting to quit smoking.
The study will evaluate the pharmacokinetics, safety and tolerability of the RespiRxâ„¢ Nicotine Inhaler compared to ... to assist smokers attempting to quit smoking. Smoking continues to be ...